# FDA recall Z-1174-2024

> **MRP, LLC dba Aquabiliti** · Class II · device recall initiated 2023-12-28.

## Product

AQUABILITI AQUASTAT 0.9% Sodium Chloride Injection syringe, USP, 5mL in 12mL, REF 2T0805; and 3mL in 12mL, REF 2T0807, intermediate cartons containing 100 syringes, shipping cases containing 400 syringes, Rx, Sterile.

## Reason for recall

The saline flush syringes may fail to meet USP criteria for stated sodium chloride content after 12 months.

## Distribution

US Nationwide distribution in the states CO, FL, NC, NY, OH, PA, TN, TX, and VA.

## Key facts

- **Recall number:** Z-1174-2024
- **Recalling firm:** MRP, LLC dba Aquabiliti
- **Classification:** Class II
- **Product type:** device
- **Status:** Ongoing
- **Initiation date:** 2023-12-28
- **Report date:** 2024-02-28

- **Voluntary/Mandated:** Voluntary: Firm initiated
- **Location:** Nashville, TN, United States

## Primary source

FDA Enforcement Reports: https://www.accessdata.fda.gov/scripts/ires/index.cfm?Product=Z-1174-2024

## Citation

> AI Analytics. FDA recall Z-1174-2024. Retrieved 2026-06-13 from https://api.ai-analytics.org/recall/Z-1174-2024. Source: US FDA. Licensed CC0.

---

*[Dataset catalog](/datasets/) · [FDA recalls dataset](/datasets/fda-recalls) · CC0 1.0*